Similar articles for PMID: 25077109

Year	Number of Results
1997	1
2001	1
2004	1
2006	1
2007	2
2008	1
2011	5
2012	6
2013	11
2014	14
2015	10
2016	16
2017	15
2018	7
2019	8
2020	4
2021	4
2024	0

1

Variation between Canadian centres in the uptake of treatment for hepatitis C by patients coinfected with HIV: a prospective cohort study.

Young J, Potter M, Cox J, Cooper C, Gill J, Hull M, Walmsley S, Klein MB. Young J, et al. CMAJ Open. 2013 Sep 24;1(3):E106-14. doi: 10.9778/cmajo.20130009. eCollection 2013 Sep. CMAJ Open. 2013. PMID: 25077109 Free PMC article.

2

Variation in hepatitis C virus treatment uptake between Canadian centres in the era of direct-acting antivirals.

Nitulescu R, Young J, Saeed S, Cooper C, Cox J, Martel-Laferriere V, Hull M, Walmsley S, Tyndall M, Wong A, Klein MB; Canadian Co-Infection Cohort Study. Nitulescu R, et al. Int J Drug Policy. 2019 Mar;65:41-49. doi: 10.1016/j.drugpo.2018.08.012. Epub 2018 Dec 26. Int J Drug Policy. 2019. PMID: 30594080

3

Previous incarceration impacts access to hepatitis C virus (HCV) treatment among HIV-HCV co-infected patients in Canada.

Kronfli N, Nitulescu R, Cox J, Moodie EE, Wong A, Cooper C, Gill J, Walmsley S, Martel-Laferrière V, Hull MW, Klein MB; Canadian Co-Infection Cohort Study. Kronfli N, et al. J Int AIDS Soc. 2018 Nov;21(11):e25197. doi: 10.1002/jia2.25197. J Int AIDS Soc. 2018. PMID: 30460791 Free PMC article.

4

Barriers to hepatitis C virus treatment in a Canadian HIV-hepatitis C virus coinfection tertiary care clinic.

McLaren M, Garber G, Cooper C. McLaren M, et al. Can J Gastroenterol. 2008 Feb;22(2):133-7. doi: 10.1155/2008/949582. Can J Gastroenterol. 2008. PMID: 18299730 Free PMC article.

5

Disparities in direct acting antivirals uptake in HIV-hepatitis C co-infected populations in Canada.

Saeed S, Strumpf EC, Moodie EE, Young J, Nitulescu R, Cox J, Wong A, Walmsely S, Cooper C, Vachon ML, Martel-Laferriere V, Hull M, Conway B, Klein MB; Canadian Co-Infection Cohort Study. Saeed S, et al. J Int AIDS Soc. 2017 Nov;20(3):e25013. doi: 10.1002/jia2.25013. J Int AIDS Soc. 2017. PMID: 29116684 Free PMC article.

6

Uptake of hepatitis C virus treatment in HIV/hepatitis C virus-coinfected patients across Europe in the era of direct-acting antivirals.

Peters L, Laut K, Resnati C, Del Campo S, Leen C, Falconer K, Trofimova T, Paduta D, Gatell J, Rauch A, Lacombe K, Domingo P, Chkhartishvili N, Zangerle R, Matulionyte R, Mitsura V, Benfield T, Zilmer K, Khromova I, Lundgren J, Rockstroh J, Mocroft A; EuroSIDA Study Group. Peters L, et al. AIDS. 2018 Sep 10;32(14):1995-2004. doi: 10.1097/QAD.0000000000001928. AIDS. 2018. PMID: 29912062 Free article.

7

Changes in quality of life, healthcare use, and substance use in HIV/hepatitis C coinfected patients after hepatitis C therapy: a prospective cohort study.

Yeung MW, Young J, Moodie E, Rollet-Kurhajec KC, Schwartzman K, Greenaway C, Cooper C, Cox J, Gill J, Hull M, Walmsley S, Klein MB. Yeung MW, et al. HIV Clin Trials. 2015 May-Jun;16(3):100-10. doi: 10.1179/501100000024. Epub 2015 May 14. HIV Clin Trials. 2015. PMID: 25972048

8

Risk Factors for Hepatitis C Virus Reinfection After Sustained Virologic Response in Patients Coinfected With HIV.

Young J, Rossi C, Gill J, Walmsley S, Cooper C, Cox J, Martel-Laferriere V, Conway B, Pick N, Vachon ML, Klein MB; Canadian Co-infection Cohort Investigators. Young J, et al. Clin Infect Dis. 2017 May 1;64(9):1154-1162. doi: 10.1093/cid/cix126. Clin Infect Dis. 2017. PMID: 28199495 Free PMC article.

9

HIV and hepatitis C virus coinfection in Canada: challenges and opportunities for reducing preventable morbidity and mortality.

Klein MB, Rollet KC, Saeed S, Cox J, Potter M, Cohen J, Conway B, Cooper C, Côté P, Gill J, Haase D, Haider S, Hull M, Moodie E, Montaner J, Pick N, Rachlis A, Rouleau D, Sandre R, Tyndall M, Walmsley S; Canadian HIV-HCV Cohort Investigators. Klein MB, et al. HIV Med. 2013 Jan;14(1):10-20. doi: 10.1111/j.1468-1293.2012.01028.x. Epub 2012 May 28. HIV Med. 2013. PMID: 22639840 Free article.

10

Positive impact of hepatitis C virus (HCV) treatment on antiretroviral treatment adherence in human immunodeficiency virus-HCV coinfected patients: one more argument for expanded access to HCV treatment for injecting drug users.

Roux P, Fugon L, Winnock M, Salmon-Céron D, Lacombe K, Sogni P, Spire B, Dabis F, Carrieri MP; ANRS-CO-13-HEPAVIH Study Group. Roux P, et al. Addiction. 2012 Jan;107(1):152-9. doi: 10.1111/j.1360-0443.2011.03608.x. Epub 2011 Oct 12. Addiction. 2012. PMID: 21819472

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

94 results

Results by year